Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

IMV Inc IMVIQ

IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIQ - Post by User

Comment by qwerty22on Dec 28, 2020 11:29am
227 Views
Post# 32187378

RE:Update on DPX-Covid19

RE:Update on DPX-Covid19

So still at the preclinical phase with more to come, no immediate plan to go into humans. They talk about the "evolution of the regulatory landscape", it seems reasonable to think this is the main driver of the constantly revised timelines. I guess the one thing I'd like more detail on is the ferret challenge study, some way to compare the response in this vaccine to others just to know we do have a competitive vaccine at least in the animal model setting. Certainly the tone of the PR suggests they think they have something that could be competitive if it ever gets into humans, after the expectation of warp speed the new regulatory landscape (which looks a lot more like the old, usual landscape) is very frustrating. With the whole population expected to be vaccinated will there be suitable volunteers for trials?


Breakthorough wrote: https://www.businesswire.com/news/home/20201228005059/en/

 

<< Previous
Bullboard Posts
Next >>